Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
31.7%
% of XLV's 60 holdings also in HRTS
47.5%
% of HRTS's 40 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.3% | 10.1% | 10.1% |
|
UNITEDHEALTH GROUP INC | 9.0% | 6.0% | 6.0% |
|
ABBOTT LABORATORIES | 4.3% | 3.8% | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% | 3.1% | 3.1% |
|
BOSTON SCIENTIFIC CORP | 2.8% | 3.0% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to HRTS
|
JOHNSON & JOHNSON | 7.5% |
|
ABBVIE INC | 4.5% |
|
INTUITIVE SURGICAL INC | 3.3% |
|
UNITEDHEALTH GROUP INC | 3.0% |
|
PFIZER INC | 2.7% |
|
STRYKER CORP | 2.4% |
|
ELI LILLY & CO | 2.2% |
|
ELEVANCE HEALTH INC | 1.9% |
|
CIGNA CORPORATION | 1.7% |
|
MERCK & CO. INC. | 1.6% |
XLV Underweight Relative to HRTS
|
BRIDGEBIO PHARMA, INC. | -4.2% |
 |
ASTRAZENECA PLC | -4.1% |
 |
NOVO NORDISK A/S-B | -3.9% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -3.9% |
|
NOVARTIS AG | -2.9% |
|
CRINETICS PHARMACEUTICALS INC | -2.6% |
|
CYTOKINETICS INC | -2.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -2.1% |
|
ALNYLAM PHARMACEUTICALS INC | -2.0% |
|
ASCENDIS PHARMA A/S | -1.6% |